Three doses of an experimental detoxified L3-derived lipooligosaccharide meningococcal vaccine offer good safety but low immunogenicity in healthy young adults.

Source:http://linkedlifedata.com/resource/pubmed/id/20660140

Download in:

View as

General Info

PMID
20660140